American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

McNeil Recalls Children's, Infants' Tylenol, Motrin, Benadryl, Zyrtec

Generic Versions of Products Not Affected, Says FDA

By News Staff

For the second time this year -- and the third time in less than nine months -- McNeil Consumer Healthcare is recalling children's and infants' liquid pain relief products.
Product Recall
The manufacturer said in an April 30 news release that it is recalling all lots that have not yet expired of certain brand-name OTC children's and infants' liquid medications, including more than 40 variations of Tylenol, Motrin, Zyrtec and Benadryl products.

A complete list of affected products is included in McNeil's news release.

The company said the products were being recalled because of manufacturing deficiencies that could affect quality, purity or potency. In a May 1 news release, FDA officials said that some of the recalled products may contain higher concentrations of active ingredients than specified, while others contain inactive ingredients that may not meet internal testing requirements. Other products may contain foreign particles.

Generic versions of the products -- acetaminophen (Tylenol), ibuprofen (Motrin), cetirizine (Zyrtec) and diphenhydramine (Benadryl) -- are not affected by the recall and are considered safe to use, the FDA said.

The agency said the potential for serious health problems with use of the recalled products is remote, but FDA officials advised parents and caregivers to not administer the medications to their children as a precaution.

Adverse reactions or quality problems experienced with use of the products can be reported to the FDA's MedWatch program.

Consumers can contact McNeil at (888) 222-6036 or online. The manufacturer is offering consumers with affected products refunds or coupons to use with replacement bottles.

In January, McNeil recalled more than 500 lots of OTC products -- including Benadryl, Rolaids, multiple formulations of both Motrin and Children's Motrin and numerous formulations of Tylenol and Children's Tylenol -- because of chemical contamination.

That recall came on the heels of a September 2009 action, in which the manufacturer recalled more than 50 lots of its liquid children's and infants' Tylenol products because of potential bacterial contamination.

Share this on AAFP Connection

Search AAFP News Now

 

Health of the Public

Remain Vigiliant for Novel Coronavirus, Says CDC

DTaP Remains in Short Supply This Summer

Though Waning, H7N9 Still Poses Pandemic Potential

AUA Says No to Routine PSA Screening

AAFP Criticizes Appeal of Plan B One-Step Ruling

AAFP to Hospitals: Stop Early Elective Deliveries

AAFP, USPSTF Differ Somewhat on HIV Screening Guidance

Zoledronic Acid Confers Both Pros, Cons

ACP Issues Guidance on PSA Screening

Abbott Recalls FreeStyle InsuLinx Blood Glucose Meter

Discuss Drug Options With Women at Risk for Breast Cancer

Shingles Vaccine Effective, But Uptake Is Low

Evidence Lacking to Make Oral Cancer Screening Recommendation

Two External Guidelines Get Qualified AAFP Endorsement

USPSTF Recommends BRCA Testing for High-risk Women

Primary Care, Public Health Look for Ways to Integrate

Malfunction Prompts Glucose Meter Recall

Evidence Lacking on PAD Screening, Says USPSTF

Azithromycin Poses Arrhythmia Risk, Says FDA

Vets With PTSD Often Prescribed Inappropriate Meds

AIM-HI Offers Grants to Combat Childhood Obesity

USPSTF Says No to Low-dose Vitamin D, Calcium to Prevent Fractures

PCV13, HibMenCY Vaccine Changes Approved by ACIP

AAFP, Other Groups Release More Choosing Wisely Lists

National Office Champions Tobacco Cessation Project Successful

USPSTF Issues Draft Statement on Glaucoma Screening

Study Examines Overuse, Inappropriate Use of Health Services

Apply to Become an AAFP Vaccine Science Fellow

Study Looks to Reduce PSA Screening Risks

AAP Issues New Clinical Guidance on Type 2 Diabetes

CDC: Adult Vaccination Rates Still Too Low

Pertussis Outbreaks Declining, but Immunization Still Key

2013 Immunization Schedules Include Several Changes

FDA Warns of Liver Injury Risk With Samsca Use

FDA Approves First Recombinant Trivalent Influenza Vaccine

AAFP, USPSTF: Screen Women of Childbearing Age for Partner Violence

Breast Cancer Screening in Older Women Costly, Likely Ineffective

CDC Gives Flu Update, Urges Continued Vaccination

Aerobic Exercise Beats Resistance Training for Weight Control